Full name
SUPER -PHARM HOLDING SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.11.Z - Non-specialized retail trade with a predominance of food, beverages, or tobacco products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.51.Z - Retail sale of textile products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
96.02.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 12,7 | 12,7 | -7,2 | -156,7 |
EBITDA | 14,7 | 14,7 | -16,9 | -215 |
Short time liabilities | 173,8 | 173,8 | 328 | 88,8 |
Equity capital | 24,3 | 24,3 | 15,5 | -36,2 |
Operating profit (EBIT) | 11,8 | 11,8 | -23,6 | -299,8 |
Assets | 266,2 | 266,2 | 421,7 | 58,4 |
Net profit (loss) | 10,4 | 10,4 | -8,8 | -185,1 |
Cash | 6,2 | 6,2 | 15,8 | 155,5 |
Liabilities and provisions for liabilities | 241,8 | 241,8 | 406,1 | 67,9 |
Net income from sale | 543,5 | 543,5 | 1311,4 | 141,3 |
Working assets | 171,2 | 171,2 | 316,2 | 84,7 |
Depreciation | 2,9 | 2,9 | 6,7 | 131,8 |
% | % | % | p.p. | |
Profitability of capital | 42,5 | 42,5 | -56,7 | -99,2 |
Equity capital to total assets | 9,1 | 9,1 | 3,7 | -5,4 |
Gross profit margin | 2,3 | 2,3 | -0,5 | -2,8 |
EBITDA Margin | 2,7 | 2,7 | -1,3 | -4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 117 | 117 | 91 | -26 |
Current financial liquidity indicator | 0.9850955009460449 | 0.9850955009460449 | 0.9085028171539307 | -0,1 |
Net dept to EBITDA | 7.054835796356201 | 7.054835796356201 | -9.734471321105957 | -16,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane